Bristol Myers Squibb
May 8, 2008
ConvaTec to belong to new owners
Private equity firms Avista Capital Partners and Nordic Capital have agreed to acquire biopharmaceutical business unit ConvaTec from Bristol-Myers Squibb Company for approximately $4.1bn, subject to adjustments ... via Pravda
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Blood thinner Coumadin gets black box warning o... (from Jan '07) | Thu | Casey | 180 |
| N.H. gets tough on drug manufacturers | Wed | Danny Haszard | 1 |
| Minnesota to get $4 million in Bristol-Myers Sq... | Wed | Sharon Hille... | 1 |
| Connecticut receiving $2 million from drug maker | Jul 16 | ark203 | 3 |
| FDA Approves Generic Cholesterol Medication (from Apr '06) | Jul 16 | WandaM | 25 |
| Graffiti Artist Banksy Unmasked as Robin Gunnin... | Jul 14 | Tal | 1 |
| Long Ordeal Over For Hostage's Connecticut Family | Jul 14 | Elaine | 4 |
Most Popular
